Caspase Inhibition in Islet Transplantation
NCT01653899
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Diabetes
Interventions
DRUG:
IDN-6556
Sponsor
University of Alberta
Collaborators
[object Object]